341 related articles for article (PubMed ID: 17309621)
61. Evaluation of the impact of tromethamine edetate disodium dihydrate on antimicrobial susceptibility of Pseudomonas aeruginosa in biofilm in vitro.
Pye CC; Singh A; Weese JS
Vet Dermatol; 2014 Apr; 25(2):120-3, e33-4. PubMed ID: 24589016
[TBL] [Abstract][Full Text] [Related]
62. Effect of adherence on antimicrobial susceptibility of Pseudomonas aeruginosa, Serratia marcescens, and Proteus mirabilis.
Fujiwara S; Miyake Y; Usui T; Suginaka H
Hiroshima J Med Sci; 1998 Mar; 47(1):1-5. PubMed ID: 9583277
[TBL] [Abstract][Full Text] [Related]
63. Antibacterial activity of Quercus ilex bark's extracts.
Berahou A; Auhmani A; Fdil N; Benharref A; Jana M; Gadhi CA
J Ethnopharmacol; 2007 Jul; 112(3):426-9. PubMed ID: 17513077
[TBL] [Abstract][Full Text] [Related]
64. Combination of 10% EDTA, Photosan, and a blue light hand-held photopolymerizer to inactivate leading oral bacteria in dentistry in vitro.
Maisch T; Wagner J; Papastamou V; Nerl HJ; Hiller KA; Szeimies RM; Schmalz G
J Appl Microbiol; 2009 Nov; 107(5):1569-78. PubMed ID: 19457024
[TBL] [Abstract][Full Text] [Related]
65. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
Cai Y; Fan Y; Wang R; An MM; Liang BB
J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
67. Role of EDTA and CSE1034 in curli formation and biofilm eradication of Klebsiella pneumoniae: a comparison with other drugs.
Chaudhary M; Payasi A
J Antibiot (Tokyo); 2012 Dec; 65(12):631-3. PubMed ID: 23093035
[No Abstract] [Full Text] [Related]
68. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae.
Verma V; Harjai K; Chhibber S
Biofouling; 2010 Aug; 26(6):729-37. PubMed ID: 20711894
[TBL] [Abstract][Full Text] [Related]
69. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment.
Verma V; Harjai K; Chhibber S
J Antimicrob Chemother; 2009 Dec; 64(6):1212-8. PubMed ID: 19808232
[TBL] [Abstract][Full Text] [Related]
70. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections?
Lönn-Stensrud J; Landin MA; Benneche T; Petersen FC; Scheie AA
J Antimicrob Chemother; 2009 Feb; 63(2):309-16. PubMed ID: 19098295
[TBL] [Abstract][Full Text] [Related]
71. The effect of fungal metabolites and of coriander seeds on the growth of pathogenic bacteria.
Dwivedi R
Ann Inst Pasteur (Paris); 1972 Aug; 123(2):311-4. PubMed ID: 4632293
[No Abstract] [Full Text] [Related]
72. Self-reinforced ciprofloxacin-releasing polylactide-co-glycolide 80/20 inhibits attachment and biofilm formation by Staphylococcus epidermidis: an in vitro study.
Niemelä SM; Länsman S; Ikäheimo I; Koskela M; Veiranto M; Suokas E; Törmälä P; Syrjälä H; Ashammakhi N
J Craniofac Surg; 2006 Sep; 17(5):950-6. PubMed ID: 17003625
[TBL] [Abstract][Full Text] [Related]
73. Low concentration of ethylenediaminetetraacetic acid (EDTA) affects biofilm formation of Listeria monocytogenes by inhibiting its initial adherence.
Chang Y; Gu W; McLandsborough L
Food Microbiol; 2012 Feb; 29(1):10-7. PubMed ID: 22029913
[TBL] [Abstract][Full Text] [Related]
74. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
Weldrick PJ; Hardman MJ; Paunov VN
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
[TBL] [Abstract][Full Text] [Related]
75. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms.
Gualtieri M; Bastide L; Villain-Guillot P; Michaux-Charachon S; Latouche J; Leonetti JP
J Antimicrob Chemother; 2006 Oct; 58(4):778-83. PubMed ID: 16880176
[TBL] [Abstract][Full Text] [Related]
76. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture.
Cross JL; Ramadan HH; Thomas JG
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):21-6. PubMed ID: 17599559
[TBL] [Abstract][Full Text] [Related]
77. In vitro antibacterial effects of topical local anesthetics.
Sedef Gocmen J; Buyukkocak U; Caglayan O; Aksoy A
J Dermatolog Treat; 2008; 19(6):351-3. PubMed ID: 18608709
[TBL] [Abstract][Full Text] [Related]
78. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: an in vitro study with clinical strains.
Ensing GT; Neut D; van Horn JR; van der Mei HC; Busscher HJ
J Antimicrob Chemother; 2006 Dec; 58(6):1287-90. PubMed ID: 17041238
[TBL] [Abstract][Full Text] [Related]
79. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli.
Carson L; Gorman SP; Gilmore BF
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):447-55. PubMed ID: 20528927
[TBL] [Abstract][Full Text] [Related]
80. Effect of chlorhexidine/EDTA/Tris against bacterial isolates from clinical specimens.
Harper WE; Epis JA
Microbios; 1987; 51(207):107-12. PubMed ID: 3116368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
